Back to results
US 5,844,003 AGranted
Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
AssigneeInnovations Foundation
InventorsWilliam G. Tatton, Carol E. Greenwood
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of deprenyl compounds to rescue damaged nerve cells in a patient and to kits containing deprenyl compounds useful for rescuing damaged nerve cells in a patient.
Claims21
A method for rescuing damaged nerve cells in a patient, comprising:
- administering to a patient having damaged nerve cells an amount of a deprenyl compound such that rescuing of damaged nerve cells occurs in the patient;
- with the proviso that the deprenyl compound in not selected from the group consisting of deprenyl, pargyline, AGN-1133, and AGN-1135, and
- wherein the deprenyl compound is represented by the structure:
- ##STR8## in which R.sub.1 is hydrogen or alkyl;
- R.sub.2 is hydrogen or alkyl;
- R.sub.3 is a single bond or alkylene;
- R.sub.4 is heterocyclyl, aryl or aralkyl;
- R.sub.5 is alkylene;
- and
- R.sub.6 is
- --C.tbd.CH;
- or a pharmaceutically acceptable salt thereof.
9 more elements
A method for rescuing damaged nerve cells in a patient, comprising;
- administering to a patient having damaged nerve cells an amount of deprenyl compound such that rescuing of damaged nerve cells occurs in the patient;
- wherein the deprenyl compound is represented by the structure. ##STR12##
Dependencies are inferred from the claim text.